Drupal.behaviors.print = function(context) {window.print();window.close();}>

Wall Street Increases Loss Estimates for Exact Sciences Following Details of Clinical Trial Plans

August 03, 2011

Wall Street Increases Loss Estimates for Exact Sciences Following Details of Clinical Trial Plans

While a number of analysts maintained prior ratings on Exact Sciences, Rodman & Renshaw downgraded the company to Perform from Outperform.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories